ES2439793T3 - Compuestos de pirimidina, su uso como inhibidores de la mTOR quinasa y de la PI3 quinasa, y su síntesis - Google Patents
Compuestos de pirimidina, su uso como inhibidores de la mTOR quinasa y de la PI3 quinasa, y su síntesis Download PDFInfo
- Publication number
- ES2439793T3 ES2439793T3 ES10716162.2T ES10716162T ES2439793T3 ES 2439793 T3 ES2439793 T3 ES 2439793T3 ES 10716162 T ES10716162 T ES 10716162T ES 2439793 T3 ES2439793 T3 ES 2439793T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- heteroaryl
- kinase
- inhibitors
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 title 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 title 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 title 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- -1 amino- Chemical class 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000003368 amide group Chemical group 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052757 nitrogen Chemical group 0.000 abstract 2
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17013809P | 2009-04-17 | 2009-04-17 | |
| US170138P | 2009-04-17 | ||
| PCT/US2010/031191 WO2010120998A1 (en) | 2009-04-17 | 2010-04-15 | Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2439793T3 true ES2439793T3 (es) | 2014-01-24 |
| ES2439793T9 ES2439793T9 (es) | 2016-03-10 |
Family
ID=42269326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10716162.2T Active ES2439793T3 (es) | 2009-04-17 | 2010-04-15 | Compuestos de pirimidina, su uso como inhibidores de la mTOR quinasa y de la PI3 quinasa, y su síntesis |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8835429B2 (enExample) |
| EP (1) | EP2419432B9 (enExample) |
| JP (1) | JP5649643B2 (enExample) |
| CA (1) | CA2755554C (enExample) |
| ES (1) | ES2439793T3 (enExample) |
| WO (1) | WO2010120998A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2542536B1 (en) | 2010-03-04 | 2015-01-21 | Cellzome Limited | Morpholino substituted urea derivatives as mtor inhibitors |
| WO2012122383A2 (en) * | 2011-03-09 | 2012-09-13 | Avila Therapeutics, Inc. | Pi3 kinase inhibitors and uses thereof |
| WO2012136622A1 (en) | 2011-04-04 | 2012-10-11 | Cellzome Limited | Dihydropyrrolo pyrimidine derivatives as mtor inhibitors |
| CA2849189A1 (en) | 2011-09-21 | 2013-03-28 | Cellzome Limited | Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| JP5995977B2 (ja) | 2011-10-07 | 2016-09-21 | セルゾーム リミテッド | Ｍｔｏｒ阻害剤としてのモルホリノ置換二環式ピリミジン尿素またはカルバメート誘導体 |
| PH12014500973A1 (en) * | 2011-11-01 | 2014-06-16 | Exelixis Inc | Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies |
| CN104230952B (zh) * | 2014-08-16 | 2017-02-01 | 沈阳药科大学 | 含有嘧啶骨架的化合物及其制备方法和用途 |
| AU2015366357B2 (en) | 2014-12-17 | 2018-07-19 | Shanghai Haiyan Pharmaceutical Technology Co. Ltd. | 2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof |
| GB202415232D0 (en) | 2024-10-16 | 2024-11-27 | Nacamed As | Composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9009A (en) * | 1852-06-08 | Bat-trap | ||
| US20060240014A1 (en) * | 2003-06-03 | 2006-10-26 | Beth Israel Deaconess Medical Center | Methods and compounds for the treatment of vascular stenosis |
| GB0520657D0 (en) * | 2005-10-11 | 2005-11-16 | Ludwig Inst Cancer Res | Pharmaceutical compounds |
| GB0525083D0 (en) * | 2005-12-09 | 2006-01-18 | Astrazeneca Ab | Pyrimidine derivatives |
| JP5534811B2 (ja) * | 2006-08-24 | 2014-07-02 | アストラゼネカ アクチボラグ | 増殖性疾患の治療に有用なモルホリノピリミジン誘導体 |
| JP2010527924A (ja) * | 2007-05-18 | 2010-08-19 | メルク・シャープ・エンド・ドーム・コーポレイション | オキソ架橋ジアゼパンオレキシン受容体アンタゴニスト |
| CA2702838A1 (en) * | 2007-10-16 | 2009-04-23 | Wyeth Llc | Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors |
-
2010
- 2010-04-15 ES ES10716162.2T patent/ES2439793T3/es active Active
- 2010-04-15 US US13/264,776 patent/US8835429B2/en not_active Expired - Fee Related
- 2010-04-15 EP EP10716162.2A patent/EP2419432B9/en not_active Not-in-force
- 2010-04-15 JP JP2012506209A patent/JP5649643B2/ja not_active Expired - Fee Related
- 2010-04-15 CA CA2755554A patent/CA2755554C/en not_active Expired - Fee Related
- 2010-04-15 WO PCT/US2010/031191 patent/WO2010120998A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US8835429B2 (en) | 2014-09-16 |
| EP2419432B9 (en) | 2016-02-17 |
| CA2755554C (en) | 2013-09-24 |
| ES2439793T9 (es) | 2016-03-10 |
| WO2010120998A1 (en) | 2010-10-21 |
| JP2012524103A (ja) | 2012-10-11 |
| CA2755554A1 (en) | 2010-10-21 |
| EP2419432A1 (en) | 2012-02-22 |
| US20120134959A1 (en) | 2012-05-31 |
| JP5649643B2 (ja) | 2015-01-07 |
| EP2419432B1 (en) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2521596T3 (es) | Combinación del compuesto GlyT1 con antipsicóticos | |
| CY1121699T1 (el) | Ενωσεις τριαζινης ως αναστολεις κινασης ρ13 και mtor | |
| ME02325B (me) | Benzoeve kiseline (1-fenil-2-piridin-4-il)-etil estri kao inhibitori fosfodiesteraze | |
| NZ629025A (en) | Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists | |
| ECSP088965A (es) | Derivados de 2-tioxantina que actúan como inhibidores de la mpo | |
| WO2007125321A3 (en) | Purine and deazapurine derivatives as pharmaceutical compounds | |
| EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
| ECSP099335A (es) | Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos | |
| EA200900924A1 (ru) | Циклизованные производные как ингибиторы eg-5 | |
| PE20090060A1 (es) | ANALOGOS DE IMIDAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE PI3 CINASA Y mTOR | |
| PE20130306A1 (es) | Morfolinopirimidinas y su uso en terapia | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| ES2600636T3 (es) | Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2 | |
| CO6251260A2 (es) | Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c. | |
| EA201001017A1 (ru) | 3h-[1,2,3]триазоло[4,5-d]пиримидиновые соединения, их применение в качестве ингибиторов киназы mtor и киназы pi3 и их синтезы | |
| NI201200192A (es) | Derivados de imidazopiridina, su procedimiento de preparación y su aplicación en terapéutica. | |
| JO3261B1 (ar) | مشتق بيريدين أحادي الحلقة | |
| SG10201806965XA (en) | 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer | |
| MX2010008637A (es) | Derivado de fenilpirrol novedoso. | |
| EA201290520A1 (ru) | Производные дифенилпиразолопиридинов, их получение и применение в качестве модуляторов нуклеарного рецептора not | |
| AR081426A1 (es) | Derivados de pirazol inhibidores del receptor sigma | |
| ES2587304T3 (es) | Derivados de diaminopirimidina y procedimientos para la preparación de los mismos | |
| MX348084B (es) | Compuestos de cetolido. | |
| AR070648A1 (es) | Derivados de bencimidazol sustituido | |
| ECSP088805A (es) | 2-(piridin-2-il)-pirimidinas como fungicidas |